Relationship Between Hyperbilirubinemia with ABO Incompatibility in Newborns at Abdul Moeloek Hospital Lampung
DOI:
https://doi.org/10.53089/medula.v11i1.205Keywords:
Bayi, hiperbilirubinemia, inkompatibilitas ABOAbstract
Bilirubin is a sequence product of red blood cells in the reticule-endothelial system. At excessive concentrations, about 5 mg/dL bilirubin will appear clinically as a yellow color on the skin and mucous membranes which is called jaundice. Jaundice can be physiological and pathological or commonly known as hyperbilirubinemia. Hyperbilirubinemia is a pathological condition that arises at the first day of birth and increasing of bilirubin levels 5 mg/dL per day rapidly, ABO incompatibility is the most common risk factor causes hyperbilirubinemia in newborns. ABO incompatibilities included in the main blood group antigen are blood group A and B which are the most common cases in newborns. This study aims to determine whether there is a relationship between incidences of hyperbilirubinemia with ABO incompatibility in newborns at Abdul Moeloek Hospital, Lampung. This is observational analytic study using cross sectional method. Total sampling method was done. Medical record was data source of this study. Data analysis was performed by chi-square test with p <0.05. The study used 325 medical records with 20% hyperbilirubinemia of newborn, 80% without hyperbilirubinemia, ABO incompatibility incidence is 20.9% and 79.1% without ABO incompatibility. Data analysis showed significant relationship of hipebilirubinemia with ABO incompatibility in newborns at Abdul Moeloek Hospital Lampung (p<0, 05). There study showed relationship between hypebilirubinemia with ABO incompatibility in newborn at Abdul Moeloek Hospital Lampung.
References
Anggraini H. Faktor-faktor yang berhubungan dengan kejadian ikterus pada neonatal. Jurnal Aisyah: Jurnal Ilmu Kesehatan. 2016 Jun 25;1(1):47-55.Wiknjosastro H. Ilmu Kebidanan. Jakarta. Yayasan Bina Pustaka Sarwono Prawirohardjo. 2007: 732-734.
Aniesah. Hubungan Inkompatibilitas ABO Dengan Angka Kejadian Hiperbilirubin Pada Bayi Baru Lahir Di Rumah Sakit Nirmala Suri Sukoharjo. 2011. [Skripsi] FK Ums: Jawa Tengah.
Ikatan Dokter Anak Indonesia. Indikasi Terapi Sinar pada Bayi Menyusui yang Kuning. Public Article.2013 [diakses 29 Mei 2016]. Tersedia dari http://www.idai.or.id.
Apriliastuti DA. Kejadian Hiperbilirubiemia Akibat Inkompatibilitas ABO. Jurnal Kebidanan. 2009;1(1).Dharmayani D, Gatot D, Rohsiswatmo R, Tridjaja B. Serogical Profile And Hemolytic Disease In Term Neonatal With ABO Incompatibility. Paediatrica Indonesian. 2013;49(4):219- 221.
Hackel E. Blood Factor Incompatibility In The Etiology Of Mental Deficiency. 2013 [diakses 29 Mei 2016].Tersedia dari http://ncbi.nlm.nih.gov/Pub Med.
Kalakheti BK, Singh R, Bhatta NK, Karki A, Baral N. Risk Of Neonatal Hyperbilirubinemia In Babies Born To 'O' Positive Mothers: A Prospective Cohort Study. Kathmandu Univ Med J (KUMJ). 2014;7(25):11-15.
Dahlan MS. Besar sampel dan cara pengambilan sampel dalam penelitian kedokteran dan kesehatan. Jakarta: Salemba Medika. 2009;34.
Nartono K. Inflamasi plasenta sebagai faktor ikterogenik neonatal pada inkompatibilitas golongan darah ABO ibu-janin.2013. Jakarta: Universitas Indonesia.
Phan OS. Kuning pada bayi; 2014 [diakses 14 November 2017]. Tersedia dari http://www.st-yohanesbosco.org/bosconiandetail.php?id=297&sub_id=112.
Sulistijono E, Gebyarani I, Corebima B. Pengaruh Karakteristik Demografis, Klinis, Dan Laboratorium Pada Neonatus Dengan Hiperbilirubinemia. Jurnal Kedokteran Brawijaya. 2013;26(4):192-193.
Sarici SU, Yurdakok M, Serdar MA, Oran O, Erdem G, Tekinalp G, et al. An Early (Sixth-Hour) Serum Bilirubin Measurement Is Useful In Predicting The Development Of Significant Hyperbilirubinemia And Severe ABO Hemolytic Disease In A Selective High-Risk Population Of Newborns With ABO Incompatibility. Pediatrics Journal. 2013;109(4):1-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 MEDULA
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.